Vendor, Camarillo, CA
Golden State Medical Supply, Inc.
UEI GQLDJJ8AQNN5, CAGE 1HT23
682 awards and $14,348,816 obligated between January 2, 2024 and September 4, 2026, 98% under full and open competition, against 2.9 offers on average where reported. 274 of the awards trace back to a SAM.gov solicitation on this site.
Sells to
Awarding agencies by dollars.
| Department of Veterans Affairs | $14,155,509 |
| Defense Logistics Agency | $193,307 |
| Federal Prison System / Bureau of Prisons | $0 |
Industries
NAICS on the awards, by dollars.
| Pharmaceutical Preparation ManufacturingNAICS 325412 | $14,348,816 |
| Medicinal and Botanical ManufacturingNAICS 325411 | $0 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 671 |
| Competed Under SAP | 7 |
| Not Competed | 4 |
| Small Business Set Aside - Total | 3 |
| Delivery Order | 537 |
| Purchase Order | 8 |
Solicitations it won
SAM.gov opportunities whose award USAspending attributes to this vendor.
- Solifenacin Award
Defense Logistics Agency, DLA Troop Support
Award noticeNAICS 325412Hauppauge, NYSPE2D2-25-R-0011Awarded to Golden State Medical Supply, Inc. for $2,380,713
Posted Sep 35 publications - Diltiazem SA Capsules (AB3)
Department of Veterans Affairs, Nac Pharmaceuticals
Award noticeNAICS 32541236E79726R0022Awarded to Golden State Medical Supply, Inc. for $10,812,162
Posted Aug 263 publications - Esomeprazole Magnesium Capsules Effective 10/19/2026 - 10/18/2027
Department of Veterans Affairs, Nac Pharmaceuticals
Award noticeNAICS 32541236E79726R0027Awarded to Golden State Medical Supply, Inc. for $9,617,169
Posted Aug 197 publications - Tolterodine Tartrate ER 24HR Capsules
Defense Logistics Agency, DLA Troop Support
Award noticeNAICS 325412SPE2D223R0001Awarded to Golden State Medical Supply, Inc. for $12,107,333
Posted Jul 215 publications - Pharm Manuf/Distr Div - FSA
Defense Logistics Agency, DLA Troop Support
Award noticeNAICS 325411SPE2D225R00100006Awarded to Golden State Medical Supply, Inc. for $133,180,441
Posted Jul 13 - Sumatriptan Succinate Tablets
Defense Logistics Agency, DLA Troop Support
Award noticeNAICS 325412SPE2D223R0003Awarded to Golden State Medical Supply, Inc. for $14,927,157
Posted Jul 13 publications - Buprenorphine Award
Department of Veterans Affairs, Nac Pharmaceuticals
Award noticeNAICS 32541236E79726R0004Awarded to Golden State Medical Supply, Inc. for $20,977,434
Posted May 75 publications - Pharm Manuf/Distr Div - FSA
Defense Logistics Agency, DLA Troop Support
Award noticeNAICS 325411SPE2D2-25-R-0019Awarded to Golden State Medical Supply, Inc. for $2,364,030
Posted May 77 publications - Olopatadine HCL 0.1% Ophthalmic Solution
Defense Logistics Agency, DLA Troop Support
Award noticeNAICS 325412SPE2D222R0117Awarded to Golden State Medical Supply, Inc. for $17,621,453
Posted May 44 publications - Trazodone - Award Notice
Defense Logistics Agency, DLA Troop Support
Award noticeNAICS 325412Chantilly, VASPE2D2-26-R-0003Awarded to Golden State Medical Supply, Inc. for $14,366,966
Posted Apr 286 publications - Rasagiline Tablets
Defense Logistics Agency, DLA Troop Support
Award noticeNAICS 325412New JerseySPE2D2-25-R-0020Awarded to Golden State Medical Supply, Inc. for $6,637,357
Posted Apr 24 publications - Dimethyl Fumarate Capsules
Department of Veterans Affairs, Nac Pharmaceuticals
Award noticeNAICS 32541236E79726R0003Awarded to Golden State Medical Supply, Inc. for $10,435,776
Posted Mar 185 publications
Awards
The 100 largest of 682 awards, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| SPE2D325F4121Delivery Order, January 13, 2025, Full and Open Competition | DLA Troop SupportDefense Logistics Agency | 4566919087!metronidazole 500 MG Tablet 100SNAICS 325412, PSC 6505 | $24 |
| SPE2D325F4247Delivery Order, January 17, 2025, Full and Open Competition | DLA Troop SupportDefense Logistics Agency | 4566971591!metronidazole 500 MG Tablet 100SNAICS 325412, PSC 6505 | $24 |
| SPE2D325F5776Delivery Order, February 6, 2025, Full and Open Competition | DLA Troop SupportDefense Logistics Agency | 4567190758!metronidazole 500 MG Tablet 100SNAICS 325412, PSC 6505 | $24 |
| SPE2D325F6273Delivery Order, February 14, 2025, Full and Open Competition | DLA Troop SupportDefense Logistics Agency | 4567273089!metronidazole 500 MG Tablet 100SNAICS 325412, PSC 6505 | $24 |
| SPE2D325F6695Delivery Order, February 21, 2025, Full and Open Competition | DLA Troop SupportDefense Logistics Agency | 4567335754!metronidazole 500 MG Tablet 100SNAICS 325412, PSC 6505 | $24 |
| SPE2D325F6921Delivery Order, February 25, 2025, Full and Open Competition | DLA Troop SupportDefense Logistics Agency | 4567375582!metronidazole 500 MG Tablet 100SNAICS 325412, PSC 6505 | $24 |
| SPE2D325F8768Delivery Order, March 28, 2025, Full and Open Competition | DLA Troop SupportDefense Logistics Agency | 4567743667!metronidazole 500 MG Tablet 100SNAICS 325412, PSC 6505 | $24 |
| SPE2D326F0657Delivery Order, October 16, 2025, Full and Open Competition | DLA Troop SupportDefense Logistics Agency | 4569753470!metronidazole 500 MG Tablet 100SNAICS 325412, PSC 6505 | $24 |
| SPE2D325F306CDelivery Order, August 11, 2025, Full and Open Competition | DLA Troop SupportDefense Logistics Agency | 4569049651!ketoconazole 2% Cream 15GMNAICS 325412, PSC 6505 | $23 |
| SPE2D326F3512Delivery Order, January 9, 2026, Full and Open Competition | DLA Troop SupportDefense Logistics Agency | 4570449584!metronidazole 500 MG Tablet 100SNAICS 325412, PSC 6505 | $23 |
| SPE2D326F031BDelivery Order, April 16, 2026, Full and Open Competition | DLA Troop SupportDefense Logistics Agency | 4571513589!metronidazole 500 MG Tablet 100SNAICS 325412, PSC 6505 | $22 |
| SPE2D326F039EDelivery Order, April 20, 2026, Full and Open Competition | DLA Troop SupportDefense Logistics Agency | 4571550147!metronidazole 500 MG Tablet 100SNAICS 325412, PSC 6505 | $22 |
| SPE2D326F057TDelivery Order, April 23, 2026, Full and Open Competition | DLA Troop SupportDefense Logistics Agency | 4571593328!metronidazole 500 MG Tablet 100SNAICS 325412, PSC 6505 | $22 |
| SPE2D326F071LDelivery Order, April 29, 2026, Full and Open Competition | DLA Troop SupportDefense Logistics Agency | 4571664255!metronidazole 500 MG Tablet 100SNAICS 325412, PSC 6505 | $22 |
| SPE2D326F092VDelivery Order, May 5, 2026, Full and Open Competition | DLA Troop SupportDefense Logistics Agency | 4571729447!metronidazole 500 MG Tablet 100SNAICS 325412, PSC 6505 | $22 |
| SPE2D326F108VDelivery Order, May 11, 2026, Full and Open Competition | DLA Troop SupportDefense Logistics Agency | 4571785650!metronidazole 500 MG Tablet 100SNAICS 325412, PSC 6505 | $22 |
| SPE2D326F134QDelivery Order, May 19, 2026, Full and Open Competition | DLA Troop SupportDefense Logistics Agency | 4571884239!metronidazole 500 MG Tablet 100SNAICS 325412, PSC 6505 | $22 |
| SPE2D326F148FDelivery Order, May 26, 2026, Full and Open Competition | DLA Troop SupportDefense Logistics Agency | 4571930514!metronidazole 500 MG Tablet 100SNAICS 325412, PSC 6505 | $22 |
| SPE2D326F5875Delivery Order, February 10, 2026, Full and Open Competition | DLA Troop SupportDefense Logistics Agency | 4570796995!metronidazole 500 MG Tablet 100SNAICS 325412, PSC 6505 | $22 |
| SPE2D326F6976Delivery Order, March 3, 2026, Full and Open Competition | DLA Troop SupportDefense Logistics Agency | 4571008995!metronidazole 500 MG Tablet 100SNAICS 325412, PSC 6505 | $22 |
| SPE2D326F8044Delivery Order, March 16, 2026, Full and Open Competition | DLA Troop SupportDefense Logistics Agency | 4571160884!metronidazole 500 MG Tablet 100SNAICS 325412, PSC 6505 | $22 |
| SPE2D326F8220Delivery Order, March 19, 2026, Full and Open Competition | DLA Troop SupportDefense Logistics Agency | 4571208364!metronidazole 500 MG Tablet 100SNAICS 325412, PSC 6505 | $22 |
| SPE2D326F8491Delivery Order, March 25, 2026, Full and Open Competition | DLA Troop SupportDefense Logistics Agency | 4571262409!metronidazole 500 MG Tablet 100SNAICS 325412, PSC 6505 | $22 |
| SPE2D326F9376Delivery Order, April 2, 2026, Full and Open Competition | DLA Troop SupportDefense Logistics Agency | 4571353942!metronidazole 500 MG Tablet 100SNAICS 325412, PSC 6505 | $22 |
| SPE2D326F9528Delivery Order, April 3, 2026, Full and Open Competition | DLA Troop SupportDefense Logistics Agency | 4571364191!metronidazole 500 MG Tablet 100SNAICS 325412, PSC 6505 | $22 |
| SPE2D326F9684Delivery Order, April 7, 2026, Full and Open Competition | DLA Troop SupportDefense Logistics Agency | 4571402510!metronidazole 500 MG Tablet 100SNAICS 325412, PSC 6505 | $22 |
| SPE2D326F9741Delivery Order, April 7, 2026, Full and Open Competition | DLA Troop SupportDefense Logistics Agency | 4571402512!metronidazole 500 MG Tablet 100SNAICS 325412, PSC 6505 | $22 |
| SPE2D326F029JDelivery Order, April 16, 2026, Full and Open Competition | DLA Troop SupportDefense Logistics Agency | 4571513588!ketoconazole 2% Cream 15GMNAICS 325412, PSC 6505 | $21 |
| SPE2D326F122VDelivery Order, May 14, 2026, Full and Open Competition | DLA Troop SupportDefense Logistics Agency | 4571834137!ketoconazole 2% Cream 15GMNAICS 325412, PSC 6505 | $21 |
| SPE2D325F233WDelivery Order, July 18, 2025, Full and Open Competition | DLA Troop SupportDefense Logistics Agency | 4568831007!ketoconazole 2% Cream 15GMNAICS 325412, PSC 6505 | $21 |
| SPE2D325F245DDelivery Order, July 22, 2025, Full and Open Competition | DLA Troop SupportDefense Logistics Agency | 4568857284!ketoconazole 2% Cream 15GMNAICS 325412, PSC 6505 | $21 |
| SPE2D325F348HDelivery Order, August 26, 2025, Full and Open Competition | DLA Troop SupportDefense Logistics Agency | 4569235336!ketoconazole 2% Cream 15GMNAICS 325412, PSC 6505 | $21 |
| SPE2D326F4281Delivery Order, January 23, 2026, Full and Open Competition | DLA Troop SupportDefense Logistics Agency | 4570605614!ketoconazole 2% Cream 15GMNAICS 325412, PSC 6505 | $21 |
| SPE2D326F3745Delivery Order, January 13, 2026, Full and Open Competition | DLA Troop SupportDefense Logistics Agency | 4570526358!ketoconazole 2% Cream 15GMNAICS 325412, PSC 6505 | $16 |
| SPE2D326F3748Delivery Order, January 13, 2026, Full and Open Competition | DLA Troop SupportDefense Logistics Agency | 4570526361!ketoconazole 2% Cream 15GMNAICS 325412, PSC 6505 | $16 |
| SPE2D326F3750Delivery Order, January 13, 2026, Full and Open Competition | DLA Troop SupportDefense Logistics Agency | 4570526352!ketoconazole 2% Cream 15GMNAICS 325412, PSC 6505 | $16 |
| SPE2D326F3751Delivery Order, January 13, 2026, Full and Open Competition | DLA Troop SupportDefense Logistics Agency | 4570526353!ketoconazole 2% Cream 15GMNAICS 325412, PSC 6505 | $16 |
| SPE2D325F3067Delivery Order, December 11, 2024, Full and Open Competition | DLA Troop SupportDefense Logistics Agency | 4566705745!benzonatate 100 MG Capsule 500SNAICS 325412, PSC 6505 | $14 |
| SPE2D324F174KDelivery Order, August 2, 2024, Full and Open Competition | DLA Troop SupportDefense Logistics Agency | 4565347321!tramadol 50 MG Tablet 100S C-IvNAICS 325412, PSC 6505 | $12 |
| SPE2D325F0762Delivery Order, October 22, 2024, Full and Open Competition | DLA Troop SupportDefense Logistics Agency | 4566193830!metformin 500 MG Tablet 100SNAICS 325412, PSC 6505 | $9 |
| 15B61626F00000115Delivery Order, July 7, 2026, Full and Open Competition | FCC VictorvilleFederal Prison System / Bureau of Prisons | Inmate Flu Shots for 2026 Flu SeasonNAICS 325412, PSC 6505 | $0 |
| 36E79725N0006Delivery Order, November 13, 2024, Full and Open Competition | Nac PharmaceuticalsDepartment of Veterans Affairs | Delivery Order for Omeprazole 40MG with Golden State Medical Supply for the Repackaging Program.NAICS 325412, PSC 6505 | $0 |
| 36E79725N0008Delivery Order, December 12, 2024, Full and Open Competition | Nac PharmaceuticalsDepartment of Veterans Affairs | Delivery Order for Omeprazole 40MG with Golden State Medical Supply for the Repackaging Program.NAICS 325412, PSC 6505 | $0 |
| 36E79719D0006March 13, 2024, Full and Open Competition, 1 offers | Nac PharmaceuticalsDepartment of Veterans Affairs | CRF and Sales Reporting ChangesNAICS 325412, PSC 6505 | $0 |
| 36E79719D0011February 26, 2024, Full and Open Competition, 2 offers | Nac PharmaceuticalsDepartment of Veterans Affairs | CRF and Sales Reporting UpdateNAICS 325412, PSC 6505 | $0 |
| 36E79719D0012February 16, 2024, Full and Open Competition, 2 offers | Nac PharmaceuticalsDepartment of Veterans Affairs | Change Timeframe for the Submission of Quarterly Sales Reports and Cost Recovery Fee to 30 Calendar Days After End of Each Fiscal Quarter.NAICS 325412, PSC 6505 | $0 |
| 36E79719D0013March 1, 2024, Full and Open Competition, 2 offers | Nac PharmaceuticalsDepartment of Veterans Affairs | Update to Cost Recovery Fee (Crf) and Submission of Quartley Sales Reports.NAICS 325412, PSC 6505 | $0 |
| 36E79719D0021March 28, 2024, Full and Open Competition, 2 offers | Nac PharmaceuticalsDepartment of Veterans Affairs | CRF Sales Submittal and Reporting ChangesNAICS 325412, PSC 6505 | $0 |
| 36E79719D0022February 26, 2024, Full and Open Competition, 2 offers | Nac PharmaceuticalsDepartment of Veterans Affairs | CRF and Sales Reporting UpdateNAICS 325412, PSC 6505 | $0 |
| 36E79719D0023February 14, 2024, Full and Open Competition, 1 offers | Nac PharmaceuticalsDepartment of Veterans Affairs | CRF and Submission of Quarterly Sales Reports Effective 2/14/2024 for Propranolol HCL Tablets with Golden State Medical Supply, INC.NAICS 325412, PSC 6505 | $0 |
| 36E79719D0025February 15, 2024, Full and Open Competition, 3 offers | Nac PharmaceuticalsDepartment of Veterans Affairs | This Modification Is Issued to Update the Terms of the CRF Payment Remittal and Submission of Quarterly Sales Reports.NAICS 325412, PSC 6505 | $0 |
| 36E79719D0030February 14, 2024, Full and Open Competition, 1 offers | Nac PharmaceuticalsDepartment of Veterans Affairs | CRF and Submission of Quarterly Sales Reports Effective 2/14/2024 for Oxcarbazepine Tablets with Golden State Medical Supply, INC. PNAICS 325412, PSC 6505 | $0 |
| 36E79719D0034February 14, 2024, Full and Open Competition, 2 offers | Nac PharmaceuticalsDepartment of Veterans Affairs | Modification for the Supplemental Changes to the CRF Payment Submittal and Sales Reporting Requirements.NAICS 325412, PSC 6505 | $0 |
| 36E79719D0035February 26, 2024, Full and Open Competition, 1 offers | Nac PharmaceuticalsDepartment of Veterans Affairs | CRF and Sales Reporting UpdateNAICS 325412, PSC 6505 | $0 |
| 36E79720D0003February 14, 2024, Full and Open Competition, 1 offers | Nac PharmaceuticalsDepartment of Veterans Affairs | Update to Cost Recovery Fee (Crf) and Submission of Quarterly Sales Reports.NAICS 325412, PSC 6505 | $0 |
| 36E79720D0007January 9, 2024, Full and Open Competition, 3 offers | Nac PharmaceuticalsDepartment of Veterans Affairs | This Modification Is Issued to Exercise the 4TH Option Year for NC 36E79720D0007 for the Period of 2/21/2024 - 2/20/2025.NAICS 325412, PSC 6505 | $0 |
| 36E79720D0009January 9, 2024, Full and Open Competition, 4 offers | Nac PharmaceuticalsDepartment of Veterans Affairs | Exercise Option Year 4 for Dalfampridine SA Tablets. Period of Performance 1/29/2024 - 1/28/2025.NAICS 325412, PSC 6505 | $0 |
| 36E79720D0014February 14, 2024, Full and Open Competition, 4 offers | Nac PharmaceuticalsDepartment of Veterans Affairs | Change Sales Report Clause for Omeprazole National Contract with Golden State Medical Supply.NAICS 325412, PSC 6505 | $0 |
| 36E79720D0015February 14, 2024, Full and Open Competition, 3 offers | Nac PharmaceuticalsDepartment of Veterans Affairs | 52.212-4(C) Contract Terms and Conditions - Changes Update to Cost Recovery Fee (Crf) and Submission of Quarterly Sales Reports 36E79720D001NAICS 325412, PSC 6505 | $0 |
| 36E79720D0017March 19, 2024, Full and Open Competition, 3 offers | Nac PharmaceuticalsDepartment of Veterans Affairs | Exercised 4TH and Final Option Year.NAICS 325412, PSC 6505 | $0 |
| 36E79720D0027February 14, 2024, Full and Open Competition, 4 offers | Nac PharmaceuticalsDepartment of Veterans Affairs | Modification for the Supplemental Changes to the CRF Payment Submittal and Sales Reporting Requirements.NAICS 325412, PSC 6505 | $0 |
| 36E79720D0033February 28, 2024, Full and Open Competition, 4 offers | Nac PharmaceuticalsDepartment of Veterans Affairs | Modification for the Supplemental Changes to the CRF Payment Submittal and Sales Reporting Requirements.NAICS 325412, PSC 6505 | $0 |
| 36E79720D0036February 14, 2024, Full and Open Competition, 3 offers | Nac PharmaceuticalsDepartment of Veterans Affairs | Update Sales Report Clause for Metformin Contract with Golden State Medical SupplyNAICS 325412, PSC 6505 | $0 |
| 36E79720D0044March 13, 2024, Full and Open Competition, 4 offers | Nac PharmaceuticalsDepartment of Veterans Affairs | CRF and Sales Reporting ChangesNAICS 325412, PSC 6505 | $0 |
| 36E79720D0045February 15, 2024, Full and Open Competition, 2 offers | Nac PharmaceuticalsDepartment of Veterans Affairs | This Modification Is Issued to Update the Terms of the CRF Payment Remittal and Submission of Quarterly Sales Reports.NAICS 325412, PSC 6505 | $0 |
| 36E79720D0051February 15, 2024, Full and Open Competition, 5 offers | Nac PharmaceuticalsDepartment of Veterans Affairs | This Modification Is Issued to Update the Terms of the CRF Payment Remittal and Submission of Quarterly Sales Reports.NAICS 325412, PSC 6505 | $0 |
| 36E79721D0001February 14, 2024, Full and Open Competition, 4 offers | Nac PharmaceuticalsDepartment of Veterans Affairs | Incorporate CRF and Submission of Quarterly Sales Reports Effective 2/14/2024 for Tacrolimus Capsules with Golden State Medical Supply, INC.NAICS 325412, PSC 6505 | $0 |
| 36E79721D0003January 17, 2024, Full and Open Competition, 3 offers | Nac PharmaceuticalsDepartment of Veterans Affairs | Exercise Option 3.NAICS 325412, PSC 6505 | $0 |
| 36E79721D0009February 14, 2024, Full and Open Competition, 3 offers | Nac PharmaceuticalsDepartment of Veterans Affairs | Incorporate CRF and Submission of Quarterly Sales Reports Effective 2/14/2024 for Metoprolol Succinate Tablets, SA with Golden State MedicalNAICS 325412, PSC 6505 | $0 |
| 36E79721D0012February 16, 2024, Full and Open Competition, 2 offers | Nac PharmaceuticalsDepartment of Veterans Affairs | Change Timeframe for the Submission of Quarterly Sales Reports and Cost Recovery Fee to 30 Calendar Days After End of Each Fiscal Quarter.NAICS 325412, PSC 6505 | $0 |
| 36E79721D0014February 9, 2024, Full and Open Competition, 4 offers | Nac PharmaceuticalsDepartment of Veterans Affairs | Exercise Option Year 3 for Cefuroxime Axetil Tablets with No Price Changes Effective Period 03-28-2024 Through 03-27-2025 Contract Number 36NAICS 325412, PSC 6505 | $0 |
| 36E79721D0028February 27, 2024, Full and Open Competition, 2 offers | Nac PharmaceuticalsDepartment of Veterans Affairs | This Modification Is Issued to Update the Terms of the CRF Payment Remittal and Submission of Quarterly Sales Reports.NAICS 325412, PSC 6505 | $0 |
| 36E79721D0029February 14, 2024, Full and Open Competition, 4 offers | Nac PharmaceuticalsDepartment of Veterans Affairs | Update to Cost Recovery Fee (Crf) and Submission of Quarterly Sales Reports.NAICS 325412, PSC 6505 | $0 |
| 36E79721D0032February 26, 2024, Full and Open Competition, 2 offers | Nac PharmaceuticalsDepartment of Veterans Affairs | CRF and Sales Reporting UpdateNAICS 325412, PSC 6505 | $0 |
| 36E79721D0034January 11, 2024, Full and Open Competition, 4 offers | Nac PharmaceuticalsDepartment of Veterans Affairs | Bilateral Modification Issued to Decrease the Price of Dimethyl Fumarate Capsules with Golden State Medical Supply, INC. Under Contract 36E7NAICS 325412, PSC 6505 | $0 |
| 36E79721D0044February 14, 2024, Full and Open Competition, 2 offers | Nac PharmaceuticalsDepartment of Veterans Affairs | Modification for the Supplemental Changes to the CRF Payment Submittal and Sales Reporting Requirements.NAICS 325412, PSC 6505 | $0 |
| 36E79721D0045February 16, 2024, Full and Open Competition, 1 offers | Nac PharmaceuticalsDepartment of Veterans Affairs | Change Timeframe for the Submission of Quarterly Sales Reports and Cost Recovery Fee to 30 Calendar Days After End of Each Fiscal Quarter.NAICS 325412, PSC 6505 | $0 |
| 36E79721D0046February 28, 2024, Full and Open Competition, 3 offers | Nac PharmaceuticalsDepartment of Veterans Affairs | Modification for the Supplemental Changes to the CRF Payment Submittal and Sales Reporting Requirements.NAICS 325412, PSC 6505 | $0 |
| 36E79722D0001January 16, 2024, Full and Open Competition, 3 offers | Nac PharmaceuticalsDepartment of Veterans Affairs | Exercise the Second Option Year for Imatinib Mesylate Tablets Contract 36E79722D0001 with Golden State Medical Supply.NAICS 325412, PSC 6505 | $0 |
| 36E79722D0003March 13, 2024, Full and Open Competition, 2 offers | Nac PharmaceuticalsDepartment of Veterans Affairs | CRF and Sales Reporting ChangesNAICS 325412, PSC 6505 | $0 |
| 36E79722D0004January 4, 2024, Full and Open Competition, 4 offers | Nac PharmaceuticalsDepartment of Veterans Affairs | Not Exercising 2ND Option Year for Etodolac Capsules and Tablets. 1ST Option Year Expires 2/19/2024.NAICS 325412, PSC 6505 | $0 |
| 36E79722D0013March 13, 2024, Full and Open Competition, 2 offers | Nac PharmaceuticalsDepartment of Veterans Affairs | CRF and Sales Reporting ChangesNAICS 325412, PSC 6505 | $0 |
| 36E79722D0027February 14, 2024, Full and Open Competition, 2 offers | Nac PharmaceuticalsDepartment of Veterans Affairs | Modification for the Supplemental Changes to the CRF Payment Submittal and Sales Reporting Requirements.NAICS 325412, PSC 6505 | $0 |
| 36E79722D0028February 28, 2024, Full and Open Competition, 2 offers | Nac PharmaceuticalsDepartment of Veterans Affairs | Modification for the Supplemental Changes to the CRF Payment Submittal and Sales Reporting Requirements.NAICS 325412, PSC 6505 | $0 |
| 36E79722D0032February 14, 2024, Full and Open Competition, 3 offers | Nac PharmaceuticalsDepartment of Veterans Affairs | Modification for the Supplemental Changes to the CRF Payment Submittal and Sales Reporting Requirements.NAICS 325412, PSC 6505 | $0 |
| 36E79722D0036February 14, 2024, Full and Open Competition, 3 offers | Nac PharmaceuticalsDepartment of Veterans Affairs | Update to Cost Recovery Fee (Crf) and Submission of Quarterly Sales Reports.NAICS 325412, PSC 6505 | $0 |
| 36E79723D0007January 29, 2024, Full and Open Competition, 4 offers | Nac PharmaceuticalsDepartment of Veterans Affairs | Exercise the First Option Year for Lidocaine 5% Ointment Tubes Contract 36E79723D0007 with Golden State Medical Supply, INC. with No Price CNAICS 325412, PSC 6505 | $0 |
| 36E79723D0008January 17, 2024, Full and Open Competition, 4 offers | Nac PharmaceuticalsDepartment of Veterans Affairs | Exercise of Option Year One for Contract 36E79723D0008 for Lacosamide Tablets with No Price Change. Period of Performance Is 02/13/2024 - 02NAICS 325412, PSC 6505 | $0 |
| 36E79723D0009February 5, 2024, Full and Open Competition, 5 offers | Nac PharmaceuticalsDepartment of Veterans Affairs | Modification to Exercise Option Year 1. Performance Period Is 2/19/2024 - 2/18/2025.NAICS 325412, PSC 6505 | $0 |
| 36E79723D0019February 27, 2024, Full and Open Competition, 3 offers | Nac PharmaceuticalsDepartment of Veterans Affairs | This Modification Is Issued to Update the Terms of the CRF Payment Remittal and Submission of Quarterly Sales Reports.NAICS 325412, PSC 6505 | $0 |
| 36E79723D0020March 13, 2024, Full and Open Competition, 2 offers | Nac PharmaceuticalsDepartment of Veterans Affairs | CRF and Sales Reporting ChangesNAICS 325412, PSC 6505 | $0 |
| 36E79723D0021February 14, 2024, Full and Open Competition, 7 offers | Nac PharmaceuticalsDepartment of Veterans Affairs | 52.212-4(C) Contract Terms and Conditions - Changes Update to Cost Recovery Fee (Crf) and Submission of Quarterly Sales Reports 36E79723D002NAICS 325412, PSC 6505 | $0 |
| 36E79723D0024March 13, 2024, Full and Open Competition, 1 offers | Nac PharmaceuticalsDepartment of Veterans Affairs | CRF and Sales Reporting ChangesNAICS 325412, PSC 6505 | $0 |
| 36E79723D0028April 17, 2024, Full and Open Competition, 2 offers | Nac PharmaceuticalsDepartment of Veterans Affairs | Cost Recovery Fee Change ModNAICS 325412, PSC 6505 | $0 |
| 36E79724D0007February 14, 2024, Full and Open Competition, 3 offers | Nac PharmaceuticalsDepartment of Veterans Affairs | CRF and Submission of Sales Reports for Acyclovir Capsules with Gsmsm.NAICS 325412, PSC 6505 | $0 |
| 36E79724D0008February 6, 2024, Full and Open Competition, 5 offersSolicitation | Nac PharmaceuticalsDepartment of Veterans Affairs | New Award for Emtricitabine 200mg/Tenofovir Disoproxil Fumarate 300MG Tablets with Gsms. Ordering Period Is 4/6/2024 to 4/5/2025 with Four ONAICS 325412, PSC 6505 | $0 |
| 36E79724D0009February 28, 2024, Full and Open Competition, 2 offersSolicitation | Nac PharmaceuticalsDepartment of Veterans Affairs | Awarded Tenofovir Disoproxil Fumarate Tablets to GSMS for Base Year and 4 ONE-YEAR Option Periods.NAICS 325412, PSC 6505 | $0 |
| 36E79724D0011February 14, 2024, Full and Open Competition, 5 offers | Nac PharmaceuticalsDepartment of Veterans Affairs | Modification for the Supplemental Changes to the CRF Payment Submittal and Sales Reporting Requirements.NAICS 325412, PSC 6505 | $0 |
| 36E79724D0013February 16, 2024, Full and Open Competition, 6 offers | Nac PharmaceuticalsDepartment of Veterans Affairs | Change Timeframe for the Submission of Quarterly Sales Reports and Cost Recovery Fee to 30 Calendar Days After End of Each Fiscal Quarter.NAICS 325412, PSC 6505 | $0 |
| 36E79724D0016January 11, 2024, Full and Open Competition, 1 offersSolicitation | Nac PharmaceuticalsDepartment of Veterans Affairs | New Award for Alvimopan Capsules with Golden State Medical Supply, INC. the Period of Performance Is March 11, 2024 to March 10, 2025 with FNAICS 325412, PSC 6505 | $0 |
- Places of performance
- CaliforniaKansasIllinoisPennsylvania
- Product and service codes
- 6505 Drugs and Biologicals6515 Medical and Surgical Instruments, Equipment, and Supplies
- Transactions
- 1,479 across 682 awards